VIVIAN MORENO: Open Payments
NPI 1821549106 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 8 payments from 7 companies in 2025. Trend: 2023 $448 · 2024 $137 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $156 |
| GENZYME CORPORATION | 1 | $122 |
| BioMarin Pharmaceutical Inc. | 1 | $43 |
| PFIZER INC. | 1 | $37 |
| ABBVIE INC. | 1 | $29 |
| HEMA Biologics, LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Hemlibra, QFITLIA, ROCTAVIAN, HYMPAVZI, MAVYRET, SEVENFACT, Alhemo.
Industry payments across AZ — which companies pay providers there.
